258EGP
- Active ingredient
- dapagliflozin+metformin
- Strength
- 10/1000 mg
- Form
- tablet
- Manufacturer
- eva pharma
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and provide cardiovascular and renal benefits in appropriate patients.
Do not use if
Contraindicated in severe renal impairment, metabolic acidosis, and hypersensitivity to either component.
Side effects
Genital fungal infections, urinary tract infections, diarrhea, nausea, dehydration, and hypoglycemia with certain combinations may occur.
Warnings
May cause lactic acidosis, ketoacidosis, dehydration, and serious urinary infections.
How it works
Combines SGLT2 inhibition that increases urinary glucose excretion with metformin-mediated reduction of hepatic glucose production.
Storage
Store at room temperature in original packaging.
